Lumos PharmaLUMO
13F holders, Q3 2024 (September 30)28holders −7
2new positions
10sold out
1famous investor
$3.87avg. 13F price*
At the end of Q3 2024, 28 institutions reported holding Lumos Pharma Inc. (LUMO) in their 13F filings, down 7 from Q2 2024. 2 opened new positions and 10 sold out. The largest holders were Private Advisor Group, LLC ($2.9M), Goldman Sachs Group Inc. ($1.4M) and Vanguard Group Inc. ($945K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Lumos Pharma Inc.
- CUSIP
- 55028X109
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $64K |
| Exits | 10 | $589K |
All 13F filers, Q2 2024 → Q3 2024: 735,478 shares bought and 724,035 shares sold, net +11,443 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Private Advisor Group, LLC | 0.02% | Add +2380.6% | 744,513 | $2.9M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -10.9% | 362,198 | $1.4M |
| Vanguard Group Inc. | 0.00% | No change | 244,082 | $945K |
| Renaissance Technologies | 0.00% | Reduce -0.9% | 213,814 | $827K |
| Jefferies Financial Group Inc. | 0.01% | No change | 120,651 | $467K |
| Greenwich Wealth Management LLC | 0.02% | No change | 76,341 | $295K |
| Wells Fargo & Company | 0.00% | Reduce -84.3% | 64,981 | $251K |
| Geode Capital Management, LLC | 0.00% | Add +8.7% | 55,148 | $213K |
| BlackRock, Inc. | 0.00% | — | 39,825 | $154K |
| Lion Point Capital, LP | 0.61% | Reduce -56.4% | 39,589 | $153K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -14.6% | 25,278 | $98K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -28.9% | 19,643 | $76K |
| Bank of New York Mellon Corp | 0.00% | No change | 11,858 | $46K |
| Wealth Advisors of Iowa, LLC | 0.02% | No change | 11,699 | $45K |
| State Street Corp. | 0.00% | No change | 11,237 | $43K |
| Two Sigma Investments, LP | 0.00% | Reduce -41.3% | 11,130 | $43K |
| Key Financial Inc | 0.01% | No change | 10,927 | $42K |
| ADAR1 Capital Management, LLC | 0.01% | New | 10,000 | $39K |
| UBS Group AG | 0.00% | New | 6,557 | $25K |
| Paladin Advisory Group, LLC | 0.01% | No change | 4,387 | $17K |
| Bank of America Corp. | 0.00% | No change | 1,800 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -65.8% | 1,225 | $5K |
| West Financial Advisors, LLC | 0.00% | No change | 784 | $3K |
| Osaic Holdings, Inc. | 0.00% | Reduce -6.5% | 290 | $1K |
| Morgan Stanley | 0.00% | Reduce -40.1% | 166 | $642 |
| JPMorgan Chase & Co. | 0.00% | No change | 13 | $50 |
| Jones Financial Companies LLLP | 0.00% | No change | 4 | $16 |
| Royal Bank of Canada | 0.00% | Reduce -35.9% | 50 | $0 |
"% of holder's portfolio" is LUMO's weight in each manager's 13F, not the share of Lumos Pharma Inc. the manager owns.